Systemic Vasculitis Prognosis and Outcome
Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07586137 · Data updated 2026-11-12
This study follows patients suspected or diagnosed with systemic vasculitis over 10 years to see how their disease progresses and what factors predict outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia Academic / other |
| Locations | 1 site (Pavia, Pavia) |
| Status | Recruiting |
| Started | February 8, 2022 |
| Main results expected | June 15, 2028 |
| Study ends | June 15, 2030 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT07586137 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults referred to secondary care with clinical suspicion or a confirmed diagnosis of systemic vasculitis who can provide informed consent.
✕Probably not a fit
Patients without systemic vasculitis or those unable to consent may not experience direct benefits from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a long-term observational programme enrolling patients referred for suspected systemic vasculitis into a prospective inception cohort. For those with an existing diagnosis, retrospective data on disease onset will be collected, and all participants will be followed at intervals aligned with standard care. The study will collect clinical features, imaging results, and biomarkers to help characterize the disease and identify prognostic factors and outcomes. Participants may consent to use of their samples and data for related projects with the same broad aims. The goal is to understand how systemic vasculitis evolves and which factors influence prognosis over a 10-year period.
Why it matters
Potential benefit: If successful, the study could clarify prognostic factors and improve risk stratification for patients with systemic vasculitis.
How similar studies have gone: Similar observational cohorts have contributed to better understanding of systemic vasculitis, though this exact inception-cohort approach is relatively distinctive in its long-term, all-comers design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing and able to give informed consent * clinical suspicion or a confirmed diagnosis of Systemic Vasculitis Exclusion Criteria: * Inability to give informed consent
Where it's running
-
Fondazione IRCCS Policlinico San Matteo, SC Reumatologia
Pavia, Pavia, Italy Recruiting
Study contacts
- Study coordinator: Carlomaurizio Montecucco, MD
- Email: c.montecucco@smatteo.pv.it
- Phone: +390382502948
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ocular Symptoms in ANCA-Associated Vasculitis
This study tests ocular changes in adults with GPA, MPA, or related vasculitis to see how the eyes are involved.
-
Reducing unnecessary medications in older adults with rheumatic conditions
This project will test whether giving doctors individualized MedSafer reports plus patient EMPOWER brochures helps people 60+ with rheumatic conditions who take five or more regular medications stop or reduce risky medicines.
-
Inventory of vocal cord lesions causing dysphonia in autoimmune disease patients
This study looks at the types of vocal cord problems that cause voice issues in people with autoimmune diseases to help improve their diagnosis and treatment.
-
Using MRI to study kidney disease and its complications
This study is testing if a special type of MRI can help find out more about kidney problems and their effects on heart health in people with acute kidney injury and chronic kidney disease.
-
National Registry for Rare Kidney Diseases
This study is collecting health information from people with rare kidney diseases to help improve treatments and create better care guidelines.
-
Longitudinal investigation of central nervous system vasculitis
This study is trying to learn more about primary central nervous system vasculitis by following patients over three years to see how the disease affects them and to find better ways to measure its activity and outlook.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.